Skip to main content
. 2013 Mar 12;138(2):427–435. doi: 10.1007/s10549-013-2469-2

Table 2.

Reasons for ending active treatment

Completed study per protocol 55 (50.5 %)
Refused further treatment 20 (18.3 %)
 • Unacceptable side effects  9 (8.3 %)
 • Reason not given 7 (6.4 %)
 • Non-compliant 2 (1.8 %)
 • Patient choice 2 (1.8 %)
Adverse event 25 (22.9 %)
Disease progression 1 (0.9 %)
Alternate treatment 1 (0.9 %)
Other medical problems 2 (1.8 %)
Other 5 (4.6 %)